| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/26/2008 | US20080153113 Tumour Markers |
| 06/26/2008 | US20080153111 Method and composition for detecting protein-protein and protein-nucleic acid interactions |
| 06/26/2008 | US20080153110 Combination Rapid Detection Cartridges For Biological and Environmental Agents, Methods of Production and Uses Thereof |
| 06/26/2008 | US20080153108 identifying Francisella tularensis vaccine candidates. It enables identification of novel vaccine candidates and quality assurance for vaccine batches, assessment of protection in vaccinates and identification of the infecting agent in vaccinates. Mice were first vaccinated with Brucella infections |
| 06/26/2008 | US20080153107 Isolated PGE synthase, provided from encoding nucleic acid. Methods of production and use. Assays for modulators, especially inhibitors, of PGE synthase activity. |
| 06/26/2008 | US20080153104 Gene Overexpressed in Cancer |
| 06/26/2008 | US20080153103 Label-Free Optical Sensing and Characterization of Biomolecules by D8 or D10 Metal Complexes |
| 06/26/2008 | US20080153102 Rooted plant assay system |
| 06/26/2008 | US20080153101 Compositions and methods for identifying agents that alter expression of survivin |
| 06/26/2008 | US20080153100 substrates having selected active chemical regions by employing elements of the substrates in assisting the localization of active chemical groups in desired regions of the substrate. The methods may include optical, chemical and/or mechanical processes for deposits |
| 06/26/2008 | US20080153099 Quantitation of Human Genomic DNA |
| 06/26/2008 | US20080153098 Methods for diagnosing and treating breast cancer based on a HER/ER ratio |
| 06/26/2008 | US20080153097 Contacting with primer and labeled reporters with non-natural bases for amplifying; determining melt temperature |
| 06/26/2008 | US20080153096 Cartridge for conducting diagnostic assays |
| 06/26/2008 | US20080153095 Triphosphates having gamma-phosphate with a detectable group attached; detection using charge coupled device camera or photodiode |
| 06/26/2008 | US20080153094 Reduction of nonspecific binding in nucleic acid assays and nucleic acid synthesis reactions |
| 06/26/2008 | US20080153093 Method for determining risk of adverse effect of irinotecan and kit for it |
| 06/26/2008 | US20080153092 Determining presence of N-acetylmuramoyl-L-alanine amidase precursor, adiponectin, ceruloplasmin, glycoprotein, heparin and plasma retinol-binding protein; kits |
| 06/26/2008 | US20080153091 Method and device for detecting the presence of target nucleic acids in a sample, and microfluidic device for use in such methods |
| 06/26/2008 | US20080153090 Circulating mRNA as diagnostic markers |
| 06/26/2008 | US20080153089 Blocked Enzyme-Probe Complex |
| 06/26/2008 | US20080153088 Cystic fibrosis transmembrane conductance regulator gene mutations |
| 06/26/2008 | US20080153087 Measuring refracted non-fluorescent light using phase contrast or Dark field optical system; distinguish X and Y chromosome-bearing sperm for in vitro fertilization |
| 06/26/2008 | US20080153086 Hybridizing cDNA from normal tissue to cDNA from an abnormal or test tissue; cDNA populations are separately tagged prior to hybridization, which allows isolation of double-stranded cDNA containing both normal and alternatively spliced molecules |
| 06/26/2008 | US20080153085 Immobilizing and irradiating to generate electromagnetic signal; determination of DNA polymerase or telomerase, cancer cells |
| 06/26/2008 | US20080153084 Obesity Markers And Uses Thereof |
| 06/26/2008 | US20080153083 Settings for recombinant adenoviral-based vaccines |
| 06/26/2008 | US20080153082 Improved stability in high salt concentration solutions, buffers; biosensors; non-nucleotide polyphosphate polymer with a recognition probe conjugated thereto; e.g. polyanion-gold nanoparticle conjugates |
| 06/26/2008 | US20080153081 Amplifying and labeling gene; hybridizing to solid support and detecting caputred fragments; kits |
| 06/26/2008 | US20080153080 Closed photobioreactor system for continued daily in situ production, separation, collection, and removal of ethanol from genetically enhanced photosynthetic organisms |
| 06/26/2008 | US20080153079 Seafood spoilage indicator |
| 06/26/2008 | US20080153077 Resemble in vivo three-dimensional matrices; networks of nanofibers and base substrate of a non-woven or woven porous substrate; use as scaffold for tissue engineering, in drug bioassay, cell culturing, immobilization of compounds from solution such as sort/purify a population of cells |
| 06/26/2008 | US20080152659 Using presence of deletion in complement Factor H-related 4 gene as evaluative tool in predicting aneurysm and vision defects |
| 06/26/2008 | US20080152651 Beta-like glycoprotein hormone polypeptide specific immunoglobulin for treatment of autoimmune, inflammatory, (such as rheumatoid arthritis, psoriasis, multiple sclerosis, toxic shock, bone marrow and organ transplantation disorders |
| 06/26/2008 | US20080152644 Using biolpolymer modulators as therapeutic tool for treatment of alzheimer's disease |
| 06/26/2008 | US20080152643 Using modulators of toll-like receptor and/or uncooridinated protein activities as therapeutic agents in treatment of diabetes, multiple sclerosis, rheumatoid arthritis and addison's diseases |
| 06/26/2008 | US20080152641 Inhibitors of Siderophore Biosynthesis in Fungi |
| 06/26/2008 | US20080152632 Promoter-reporter cells for determining drug metabolism, drug interactions, and the effects of allotype variation |
| 06/26/2008 | US20080152630 Method of generation and expansion of tissue-progenitor cells and mature tissue cells from intact bone marrow or intact umbilical cord tissue |
| 06/26/2008 | US20080152620 Hemopoietic cytokine for use in diagnosis, prevention and treatment of skin and respiratory disorders |
| 06/26/2008 | US20080152618 Using tumor necrosis factor superfamily of ligands as therapeutic tool in treatment and prevention of cell proliferative disorders |
| 06/26/2008 | US20080152589 Diagnostics and Therapeutics of Neurological Disease |
| 06/26/2008 | US20080151088 Switching Circuit Arrangement |
| 06/26/2008 | US20080149498 microfluidic device for detecting biomolecules nucleic acids or proteins; electrode detects voltage corresponding to surface potential which changes in accordance with a concentration of biomolecules; connected to switching transistor; accurate measurement; quantitative analysis |
| 06/26/2008 | US20080149484 Method of detecting analyte-molecule interactions |
| 06/26/2008 | DE112006000731T5 Assay zur Messung von asymmetrischem Methylarginin in einer biologischen Probe Assay for the measurement of an asymmetric methylarginine in a biological sample |
| 06/26/2008 | DE102006062398A1 Verfahren zur Erkennung und/oder Charakterisierung zellulärer Aktivitätsmuster, Verwendung von Toll-like-Rezeptor-Liganden (TLR-Liganden) und ein Kit Methods for the detection and / or characterization of cellular activity patterns, use of Toll-like receptor ligands (TLR) ligands and kit |
| 06/26/2008 | DE102006060824A1 Identifying the preferential target antigens of antitumor T cells comprises transfecting autologous dendritic or B cells with a selection of mRNAs coding for tumor-associated antigens |
| 06/26/2008 | DE102006060112A1 Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM Diagnosis and risk stratification using the new marker CT proADM |
| 06/26/2008 | CA2766173A1 Method for replicating influenza virus in culture |
| 06/26/2008 | CA2681937A1 Methods and compositions for the detection of a nucleic acid by a cleavage reaction |
| 06/26/2008 | CA2679089A1 Formulation |
| 06/26/2008 | CA2677559A1 A method based on a breath test for the detection of pathogen microorganisms |
| 06/26/2008 | CA2675245A1 Use of lecithin:retinol acyl transferase gene promoter methylation in evaluating the cancer state of a subject |
| 06/26/2008 | CA2673222A1 Variants of vegfr and their use in the diagnosis and treatment of pregnancy associated medical conditions |
| 06/26/2008 | CA2673174A1 Artificial selection method and reagents |
| 06/26/2008 | CA2673092A1 Methods and compositions for the assessment of cardiovascular function and disorders |
| 06/26/2008 | CA2672878A1 Methods and compositions for treating il-4 or il-13 related fibrosis related pathologies |
| 06/26/2008 | CA2671674A1 Genes encoding a novel type of lysophophatidylcholine acyltransferases and their use to increase triacylglycerol production and/or modify fatty acid composition |
| 06/26/2008 | CA2670836A1 Treatment of pigs with pcv2 antigen |
| 06/26/2008 | CA2670519A1 Enzyme detection techniques |
| 06/26/2008 | CA2670516A1 Assessment of patients with sepsis to determine a requirement for therapeutic intervention with an antiinflammatory and/or anticoagulatory agent |
| 06/26/2008 | CA2662506A1 Glms riboswitches, structure-based compound design with glms riboswitches, and methods and compositions for use of and with glms riboswitches |
| 06/26/2008 | CA2660436A1 Enzyme containing liquid and delivery system for detection of analytes on surfaces |
| 06/25/2008 | EP1936381A1 Ptpase inhibitors and method of using same |
| 06/25/2008 | EP1936351A2 A method and a system for determination of particles in a liquid sample |
| 06/25/2008 | EP1935992A2 Multiplexed nucleic acid analysis with high specificity for human papilloma virus |
| 06/25/2008 | EP1935991A2 Nucleic acid vaccines for prevention of flavivirus infection |
| 06/25/2008 | EP1935990A2 Apparatus having reduced noise and method of using the apparatus for detecting ionic materials |
| 06/25/2008 | EP1935989A1 Method for determination of the length of g-tail sequence and kit for the method |
| 06/25/2008 | EP1935988A1 Method of constructing gene expression image and system for constructing gene expression image |
| 06/25/2008 | EP1935987A1 Detection of gene expression in cells by scanning FCS |
| 06/25/2008 | EP1935986A2 Luminogenic and fluorogenic compounds and methods to detect molecules or conditions |
| 06/25/2008 | EP1935985A1 Method of detecting reactive metabolite |
| 06/25/2008 | EP1935984A1 Screening method for the identification of a preservative |
| 06/25/2008 | EP1935983A2 Method for determination of biological particles in blood |
| 06/25/2008 | EP1935982A2 Diagnostic kit and method for the quantitative determination of the expression of the maxi-k channel |
| 06/25/2008 | EP1935980A1 Mutant luciferase |
| 06/25/2008 | EP1935979A2 Antigenic meningococcal peptides |
| 06/25/2008 | EP1935978A1 Method of controlling decomposition of protein by tetracycline antibiotic |
| 06/25/2008 | EP1935977A1 TRANSCRIPTIONAL REGULATION OF HIGH AFFINITY IgE RECEPTOR -CHAIN |
| 06/25/2008 | EP1935899A1 Nucleotide and protein sequence of mammastatin and methods of use |
| 06/25/2008 | EP1935496A1 Device and/or method for the detection of amplified nucleotides sequences on micro-arrays |
| 06/25/2008 | EP1935484A2 Oligomer probe array chip, related mask and analysis method |
| 06/25/2008 | EP1935331A2 Process for the preparation of modified electrodes, electrodes prepared with said process, and enzymatic biosensors comprising said electrodes |
| 06/25/2008 | EP1934862A1 Gene expression profiling for identification of prognostic subclasses in nasopharyngeal carcinomas |
| 06/25/2008 | EP1934615A2 Methods and materials for identifying the origin of a carcinoma of unknown primary origin |
| 06/25/2008 | EP1934613A2 Sequences for detection and identification of methicillin-resistant staphylococcus aureus (mrsa) of mrej types xi to xx |
| 06/25/2008 | EP1934611A2 Vhh for the diagnosis, prevention and treatment of diseases associated with protein aggregates |
| 06/25/2008 | EP1934598A2 Treatment and diagnosis of obligate intracellular pathogens |
| 06/25/2008 | EP1934591A1 Gated voltammetry |
| 06/25/2008 | EP1934378A2 Methods for diagnosing pancreatic cancer |
| 06/25/2008 | EP1934377A2 Methods and compositions for identifying biomarkers useful in diagnosis and/or treatment of biological states |
| 06/25/2008 | EP1934376A2 Dna microarray for rapid identification of candida albicans in blood cultures. |
| 06/25/2008 | EP1934375A1 Means and methods for the prediction of joint destruction |
| 06/25/2008 | EP1934374A2 Non-fluorescent energy transfer |
| 06/25/2008 | EP1934373A2 Salivary protein and rna for breast cancer detection |
| 06/25/2008 | EP1934371A1 Snps in the apob gene and susceptibility to increased levels of alat following ximelagatran administration |
| 06/25/2008 | EP1934370A2 Cancer therapy prognosis and target |
| 06/25/2008 | EP1934369A2 Methods and nucleic acids for the analysis of gene expression associated with tissue classification |